RightFit Trial Directory

Schizophrenia clinical trials in New Haven, CT

5 recruiting schizophrenia studies with a site in New Haven, CT.

All trials in New Haven, CT · All Schizophrenia trials

RecruitingPhase 3NCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents

Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company

New Haven, CT · +55 more sites

RecruitingPhase 2NCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

Sponsor: Eli Lilly and Company

Hartford, CT · New Haven, CT · +30 more sites

RecruitingPhase not listedNCT01730781

Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning

Sponsor: Yale University

New Haven, CT

RecruitingPhase 2 / Phase 3NCT06191965

MitoQ for Early-phase Schizophrenia-spectrum Disorder and Mitochondrial Dysfunction

Sponsor: Mclean Hospital

New Haven, CT · +1 more sites

RecruitingEarly Phase 1NCT04366518

Toward a Computationally-Informed, Personalized Treatment for Hallucinations

Sponsor: Yale University

New Haven, CT

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.